Unlearn Platform

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

EleutherAI is an open-source AI research platform that focuses on discussing and disseminating cutting-edge research in the field of artificial intelligence. The platform provides updates on various research projects, including Mechanistic Anomaly Detection, Automated Interpretability for Sparse Autoencoder Features, Experiments in Generalization, Concept Erasure, Knowledge Elicitation, and more. EleutherAI aims to foster collaboration and innovation in the AI community by sharing insights and advancements in the field.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Dimensions AI is an advanced scientific research database that provides a suite of research applications and time-saving solutions for intelligent discovery and faster insight. It hosts the largest collection of interconnected global research data, including publications, clinical trials, patents, policy documents, grants, datasets, and online citations. The platform offers easy-to-understand visualizations, purpose-built applications, and integrated AI technology to speed up research interpretation and analysis. Dimensions is designed to propel research by connecting the dots across the research ecosystem and saving researchers hours of time.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

The Stanford Artificial Intelligence Laboratory (SAIL) is a center of excellence for Artificial Intelligence research, teaching, theory, and practice since its founding in 1963. SAIL faculty and students are committed to developing the theoretical foundations of AI, advancing the state-of-the-art in AI technologies, and applying AI to address real-world problems. SAIL is a vibrant and collaborative community of researchers, students, and staff who are passionate about AI and its potential to make the world a better place.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Genesis Therapeutics is a cutting-edge platform that leverages molecular AI technology to discover and develop innovative medicines with exceptional potency and selectivity. The platform, known as GEMS (Generative AI for Drug Discovery), combines AI and physics research to identify drug candidates against challenging targets at an accelerated pace. The company's approach involves designing highly potent and selective drugs for chemically complex targets, driven by a team of collaborative minds across AI and biotech disciplines. Genesis Therapeutics is dedicated to advancing breakthrough medicines and bringing new hope to patients through its unique blend of technology and expertise.

AlphaSignal is a leading technical newsletter in the field of Artificial Intelligence (AI), providing a daily 5-minute summary of the latest breakthrough news, models, research, and repositories. It aims to keep AI developers and researchers up to date with the most relevant topics discussed by top researchers in the industry. The newsletter covers state-of-the-art projects, notebooks, and GitHub repositories, offering valuable insights for practitioners in the AI domain.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

Opinionate is an AI-powered tool designed to enhance decision-making and strengthen arguments by steelmanning viewpoints. Users can engage in debates, generate topics, and challenge ideas with the help of artificial intelligence. The platform offers a user-friendly interface for individuals looking to improve their critical thinking skills and engage in constructive discussions.

Collective[i] is an AI-powered platform that helps businesses optimize their sales processes by leveraging AI technology to forecast sales, improve productivity, and grow revenue. The platform provides insights, automates tasks, and enhances decision-making to guide teams towards optimal outcomes. Collective[i] offers applications such as Intelligent WriteBack™ for data cleansing and automation, C[i]™ for Sales for buyer-centric selling, and Intelligence.com® for supporting a community of Connectors™. The platform prioritizes enterprise-level security and privacy, ensuring the confidentiality and integrity of business information.

Lime is an AI-powered data research assistant designed to streamline and enhance the data research process. It leverages artificial intelligence to assist users in gathering, analyzing, and interpreting data efficiently and accurately. Lime aims to simplify complex data research tasks and provide valuable insights to users, ultimately saving time and improving decision-making processes.

AutoPredict is an AI application that predicts how long a car will last by analyzing over 100 million data points. It offers accurate estimates of a car's life span, providing users with valuable insights into their vehicle's longevity. In addition to the prediction feature, AutoPredict also offers an API for businesses to integrate the predictions and statistics into their operations. The AutoPredict Blog shares insights and statistics discovered during the development of the AI model.

Aspect is an AI interview notes application designed to streamline and enhance the interview process for recruiters and hiring teams. It leverages artificial intelligence to record, transcribe, highlight, and summarize interviews, allowing users to focus on engaging with candidates and making data-driven decisions. The platform seamlessly integrates with Applicant Tracking Systems (ATS) and offers features such as automated note-taking, interview summaries, and scorecard autofill. Aspect is trusted by leading organizations worldwide and is praised for its efficiency, productivity boost, and user-friendly interface.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that aims to accelerate drug development by providing accurate crystal structure predictions for small molecule drugs. The application helps in de-risking pipelines, optimizing solid-state formulations, and avoiding late-stage surprises through cutting-edge AI technology. Lavo Life Sciences combines expertise in AI and computational chemistry to offer fast and efficient solutions for drug development teams, enabling them to discover novel polymorphs and make informed decisions to enhance drug development processes.

FutureGPT is an AI tool that leverages the power of GPT-4 to provide advanced predictive capabilities. Users can enhance their results by utilizing this tool, which offers paid predictions. By enabling JavaScript, users can access the app and explore its features to receive accurate and insightful predictions for various purposes. FutureGPT aims to streamline decision-making processes and optimize outcomes through cutting-edge AI technology.

The website offers a precision workflow tool for enterprises in the finance industry, combining AI technology with human oversight to empower financial decisions. It provides features such as accurate search citations, multilingual models, and complex human-in-loop automation. The tool integrates seamlessly with existing platforms, offers time savings, and self-improving models. It is backed by innovative generative AI solutions and neural search capabilities, with a focus on transforming data processes and decision-making in finance.

Synthace is a software and expertise platform designed for Discovery Biology Teams to streamline and optimize their experiments in assay development, media optimization, and purification process development. The platform offers software solutions, training, and on-site support from specialists to help scientists conduct experiments more efficiently and effectively. By leveraging multifactorial methods and automation, Synthace aims to accelerate drug discovery processes and deliver faster, definitive results.

LotseAI is an AI-powered program management tool designed to streamline projects, align teams, and enhance decision-making. It offers secure integrations with popular tools like Notion, Google Docs, Jira, Trello, Asana, Slack, and more. LotseAI provides features such as effortless information retrieval, seamless tool integration, AI-powered reporting & insights, and dynamic tools for dynamic leaders. It helps users free up time from manual tasks, stay ahead of potential roadblocks, and keep stakeholders informed and engaged.

Alan AI is an advanced conversational AI platform that offers a wide range of AI solutions for various industries. It simplifies tasks, enhances business operations, and empowers sales strategies through AI technology. The platform provides features like question answering, semantic search, reporting, private data sources, and context awareness. With a focus on actionable AI, Alan AI aims to redefine learning and streamline decision-making processes. It offers a comprehensive suite of tools for developers, including technology architecture overview, integration, deployment, and analytics. Alan AI stands out for its innovative approach to AI reasoning, transparency, and control, making it a valuable asset for organizations seeking to leverage AI capabilities.

ThirdI is an AI-led digital marketing growth platform that simplifies marketing campaigns, realizes ROI, and saves man hours by generating meaningful insights and impactful recommendations. The platform offers maximum insights with minimal distracting graphs, AI-led recommendations, and instant impact reports for quick actions. ThirdI excels at solving business problems with full-funnel understanding, marketing automation for efficiency, and improved visibility into marketing spend. The platform stands out with features like deep data analysis, simplified marketing campaigns, and enhanced decision-making capabilities.

EquBot is an AI tool designed for investment and wealth management. It offers non-advisory institutional solutions powered by IBM Watson. The tool can be accessed at www.QuantumStreetAI.com. EquBot is based in San Francisco, California, and provides advanced AI-driven services to optimize investment decisions and wealth management strategies.

Somoon.ai is an AI-powered platform that specializes in analyzing job postings from both startups and large corporations to provide tailored analysis services. With accumulated insights from 525 companies and 39,764 job postings, Somoon.ai offers curated content related to SaaS, domestic game companies, startups, AI companies, well-known corporations, and more. The platform aims to accelerate digital transformation, enhance productivity, and efficiency in businesses by offering innovative solutions and services.

Azoo is an AI-powered platform that offers a wide range of services in various categories such as logistics, animal, consumer commerce, real estate, law, and finance. It provides tools for data analysis, event management, and guides for users. The platform is designed to streamline processes, enhance decision-making, and improve efficiency in different industries. Azoo is developed by Cubig Corp., a company based in Seoul, South Korea, and aims to revolutionize the way businesses operate through innovative AI solutions.

Prototide is an AI tool designed to streamline design iterations by providing real-time AI insights. It helps elevate design quality and decision-making speed by offering targeted, actionable insights directly in the browser. Users can receive clear feedback, make informed decisions, and enhance their designs with precision. Prototide values user privacy and collects minimal personal information for login and communication purposes. The tool offers a demo with 3 free runs to showcase its workflow enhancement capabilities.

Openfabric is an AI tool designed to provide users with a simple and accessible way to leverage artificial intelligence technology. The platform offers a user-friendly interface that allows individuals to easily integrate AI capabilities into their projects and workflows. With Openfabric, users can harness the power of AI without the need for extensive technical knowledge or expertise. Whether you are a beginner or an experienced professional, Openfabric empowers you to incorporate AI into your work seamlessly and efficiently.

IBM offers artificial intelligence solutions designed to help businesses leverage AI technologies for increased productivity and efficiency. Their adaptive AI solutions are tailored to solve real business problems, providing choice, flexibility, transparency, and trust. IBM's AI offerings include watsonx platform, Granite models, AI consulting services, and hybrid cloud solutions, enabling businesses to scale AI across various functions. From automation to decision-making, IBM's AI capabilities can optimize processes, drive insights, and accelerate value creation, enhancing competitive advantage across industries like finance, healthcare, and government.

SavvyHub.ai is an AI-powered platform designed to revolutionize the way businesses operate by leveraging artificial intelligence to streamline operations and boost productivity. With a focus on machine learning, deep learning, and innovative AI models, SavvyHub.ai offers a suite of tools to automate tasks, enhance decision-making, and drive growth for enterprises. The platform aims to simplify AI implementation for businesses, providing trusted expertise and game-changing solutions to navigate the complexities of AI technology.

Ambient is an AI-powered assistant designed for Chiefs of Staff, Managers, and Founders to enhance meeting productivity and task management. It offers features such as AI Meeting Note Taking, Email Analysis, Meeting Series Management, Slack Summarization, and Ambient Culture Security. The application aims to streamline meeting processes, improve decision-making, and increase efficiency for fast-moving teams.

Globality is an AI-enabled platform that offers autonomous sourcing solutions for modern, global enterprises. The platform leverages AI to provide guidance and insight throughout the sourcing process, enabling businesses to save money, accelerate decision-making, and create new investment opportunities. Globality guarantees significant ROI in the first year and empowers organizations to spend smarter by cutting costs and driving growth. The platform automates sourcing, enhances visibility and analytics, and enables more strategic decision-making for procurement teams.

Storytell.ai is an AI-powered platform designed to amplify team productivity by providing business-grade intelligence across data. It offers features such as SmartChat™, tagging, and content structuring to enhance work, life, and play experiences. Trusted by users across various industries, Storytell.ai leverages AI technology to streamline tasks and decision-making processes, ultimately leading to increased efficiency and profitability.

BrightHire is an interview intelligence platform that leverages AI to streamline the hiring process. It helps in creating efficient interview plans, improving interview consistency, saving time with automated interview notes, enhancing decision-making speed and quality, and providing actionable talent insights. The platform aims to transform the quality of hire by offering real-time interviewer guidance, AI-powered interview notes, and collaboration tools for better hiring decisions.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers solutions to accelerate trial timelines, enhance decision-making with digital twins, and identify sensitive clinical outcomes. The platform provides unparalleled precision in predicting clinical outcomes and is designed to put the power of AI in the hands of users. Unlearn.ai, Inc. focuses on accelerating clinical development in various medical fields through innovative AI technologies.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Abridge is an enterprise-grade AI platform for clinical conversations that transforms patient-clinician conversations into structured clinical notes in real-time. It saves hours of time-consuming documentation per clinician every month, provides clinically accurate summaries and medical terms across specialties, recognizes and takes accurate notes across a wide range of languages, and creates complete, highly accurate, structured clinical note drafts. Abridge is integrated directly inside Epic, allowing clinicians to harness its power without leaving the platform. The application aims to return time to teams, clarity to patients, and efficiencies to healthcare systems, ultimately reducing burnout and improving overall healthcare experiences.

Ubie is a medical AI application that offers a symptom checker and helps users find possible causes for their symptoms. Developed by doctors, Ubie's AI-powered system generates personalized reports on potential health issues based on a user's symptoms and personal information. The application aims to provide quick and accurate health information to users, guiding them on when to see a doctor, what might be causing their symptoms, and treatment information. Ubie values quality and safety, continuously improving its AI in collaboration with medical professionals worldwide.

RejuveAI is a decentralized token-based system that aims to democratize longevity globally. The Longevity App allows users to monitor essential health metrics, enhance lifespan, and earn RJV tokens. The application leverages revolutionary AI technology for human body analysis, collaborating with researchers, clinics, and data enthusiasts to combat aging. By harnessing sophisticated AI models and neural nets, Bayesian nets, simulations, and the AGI engine, RejuveAI targets in-depth representation of living systems. The platform offers exclusive discounts on travel, supplements, medical tests, and longevity therapies, making innovative outcomes affordable and accessible.

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with advanced AI technology to detect conditions such as acute ST-elevation myocardial infarction (STEMI) and reduced Left Ventricular Ejection Fraction (LVEF) within seconds. PMcardio aims to streamline clinical decision-making, enhance diagnostic accuracy, and improve patient care by leveraging AI algorithms trained on millions of patient outcomes. The platform is designed to ensure standardized ECG reports, facilitate care coordination, and meet the highest standards of quality and security in healthcare settings.

Glass Health is an AI-powered clinical decision support platform that empowers clinicians by providing tools to develop differential diagnoses and draft clinical plans. The platform combines cutting-edge AI technology with evidence-based medical knowledge to streamline diagnostic decisions and optimize clinician workflows. Glass Health's mission is to leverage technology to enhance the practice of medicine, increase diagnostic accuracy, implement evidence-based medicine, promote health equity, and improve patient outcomes globally. The platform is built by clinicians, for clinicians, with a deep commitment to safety, ethics, and alignment.

Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Sully.ai is the #1 all-in-one AI solution designed to save doctors' time by creating superhuman doctors. The platform offers a comprehensive set of features such as pre-visit screening, decision support, scribing, diagnosis assistance, clinical planning, and post-visit automations. Sully.ai is an automation platform that works seamlessly with Electronic Medical Records (EMR) systems, providing personalized and multilingual support for healthcare professionals. The AI model is HIPAA compliant and trained on real-life doctor encounters to enhance decision-making and streamline administrative tasks. With proven results in reducing repetitive tasks and improving efficiency, Sully.ai aims to transform healthcare delivery by empowering doctors to focus on patient care.

Neural Consult is a cutting-edge AI-powered medical education platform that offers personalized learning tools to empower medical students. The platform provides unlimited board questions, Anki cards, clinical simulations, and more, tailored to individual study needs. With features like question generation, lecture summaries, differential diagnosis, and AI-powered case simulations, Neural Consult revolutionizes the way medical students learn and prepare for exams. Trusted by students at top medical schools, Neural Consult aims to enhance clinical reasoning, memorization skills, and overall learning efficiency through innovative AI technology.

Neuralink is a pioneering brain-computer interface (BCI) application that aims to redefine human capabilities by creating a generalized brain interface to restore autonomy to individuals with unmet medical needs. The application focuses on developing fully implantable BCIs that allow users, particularly those with quadriplegia, to control computers and mobile devices using their thoughts. Neuralink's innovative technology includes advanced chips, biocompatible enclosures, and surgical robots for precise implantation. The application prioritizes safety, accessibility, and reliability in its engineering process, with future goals of restoring vision, motor function, and speech capabilities.

Medical Brain is an AI-powered clinical assistant designed for both patients and providers. It engages with users to identify health risks and care gaps early, providing actionable insights and guidance to improve outcomes and intercept high-cost ER visits. The platform monitors patients 24/7, aggregates and understands all patient data, and generates real-time actions based on AI clinical decision support and automation. Medical Brain incorporates evidence-based best practices in various clinical modules and continuously learns from user experiences to enhance efficiency and intelligence.

Health Imaging is an AI-powered platform that focuses on providing cutting-edge solutions in medical imaging and healthcare management. The platform offers a wide range of features and tools that leverage artificial intelligence to enhance diagnostic accuracy, streamline workflows, and improve patient care. From advanced imaging technologies to AI-based training solutions, Health Imaging is at the forefront of innovation in the healthcare industry.

Simbo AI is a Gen AI platform designed for healthcare enterprises, offering autonomous applications for medical practice automation. It combines LLM and symbolic knowledge bases to provide hallucination-free responses. The platform is fully controllable, consistent, secure, and responsible, ensuring accurate and reliable AI interactions. Simbo AI utilizes Symbolic RAG technology with Lossless NLU for exact search and fact-checking capabilities. It aims to automate medical practices, reduce costs, and improve patient care, ultimately enhancing the lives of doctors and patients.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

Cercle is an AI platform that advances healthcare for women by transforming healthcare data into real-time, high-quality insights. The platform caters to women's healthcare providers, payors, and pharma companies, helping them run more efficient businesses and provide personalized care. Cercle's Biomedical Graph unlocks insights at unprecedented speed and accuracy, optimizing patient care and improving outcomes in areas such as assisted reproduction and fertility processes.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.